Plasma Proteome Profiling to Assess Human Health and Disease

Philipp E. Geyer(University of Copenhagen), Nils A. Kulak(Max Planck Institute of Biochemistry), Garwin Pichler(Max Planck Institute of Biochemistry), Lesca M. Holdt(Ludwig-Maximilians-Universität München), Daniel Teupser(Ludwig-Maximilians-Universität München), Matthias Mann(University of Copenhagen)
Cell Systems
March 1, 2016
Cited by 770Open Access
Full Text

Abstract

Proteins in the circulatory system mirror an individual's physiology. In daily clinical practice, protein levels are generally determined using single-protein immunoassays. High-throughput, quantitative analysis using mass-spectrometry-based proteomics of blood, plasma, and serum would be advantageous but is challenging because of the high dynamic range of protein abundances. Here, we introduce a rapid and robust "plasma proteome profiling" pipeline. This single-run shotgun proteomic workflow does not require protein depletion and enables quantitative analysis of hundreds of plasma proteomes from 1 μl single finger pricks with 20 min gradients. The apolipoprotein family, inflammatory markers such as C-reactive protein, gender-related proteins, and >40 FDA-approved biomarkers are reproducibly quantified (CV <20% with label-free quantification). Furthermore, we functionally interpret a 1,000-protein, quantitative plasma proteome obtained by simple peptide pre-fractionation. Plasma proteome profiling delivers an informative portrait of a person's health state, and we envision its large-scale use in biomedicine.


Related Papers

No related papers found

Powered by citation graph analysis